JP2018080173A5 - - Google Patents

Download PDF

Info

Publication number
JP2018080173A5
JP2018080173A5 JP2017237159A JP2017237159A JP2018080173A5 JP 2018080173 A5 JP2018080173 A5 JP 2018080173A5 JP 2017237159 A JP2017237159 A JP 2017237159A JP 2017237159 A JP2017237159 A JP 2017237159A JP 2018080173 A5 JP2018080173 A5 JP 2018080173A5
Authority
JP
Japan
Prior art keywords
carbonyl
phenyl
amino
cyano
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017237159A
Other languages
English (en)
Japanese (ja)
Other versions
JP6760249B2 (ja
JP2018080173A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018080173A publication Critical patent/JP2018080173A/ja
Publication of JP2018080173A5 publication Critical patent/JP2018080173A5/ja
Application granted granted Critical
Publication of JP6760249B2 publication Critical patent/JP6760249B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017237159A 2015-01-09 2017-12-11 三環性スピロ化合物 Active JP6760249B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015002712 2015-01-09
JP2015002712 2015-01-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016568753A Division JP6269862B2 (ja) 2015-01-09 2016-01-08 三環性スピロ化合物

Publications (3)

Publication Number Publication Date
JP2018080173A JP2018080173A (ja) 2018-05-24
JP2018080173A5 true JP2018080173A5 (enExample) 2019-02-14
JP6760249B2 JP6760249B2 (ja) 2020-09-23

Family

ID=56356032

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016568753A Active JP6269862B2 (ja) 2015-01-09 2016-01-08 三環性スピロ化合物
JP2017237159A Active JP6760249B2 (ja) 2015-01-09 2017-12-11 三環性スピロ化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016568753A Active JP6269862B2 (ja) 2015-01-09 2016-01-08 三環性スピロ化合物

Country Status (22)

Country Link
US (4) US10077247B2 (enExample)
EP (2) EP3243813B9 (enExample)
JP (2) JP6269862B2 (enExample)
KR (2) KR102559499B1 (enExample)
CN (2) CN111039916B (enExample)
AU (1) AU2016205680B2 (enExample)
BR (1) BR112017014740B1 (enExample)
DK (1) DK3243813T3 (enExample)
ES (1) ES2839203T3 (enExample)
HU (1) HUE052969T2 (enExample)
IL (1) IL253361B (enExample)
MX (2) MX389142B (enExample)
MY (1) MY196172A (enExample)
NZ (1) NZ733575A (enExample)
PH (1) PH12017501255B1 (enExample)
PL (1) PL3243813T3 (enExample)
PT (1) PT3243813T (enExample)
RU (1) RU2707073C2 (enExample)
SG (2) SG10201912589XA (enExample)
TW (8) TWI739666B (enExample)
WO (1) WO2016111347A1 (enExample)
ZA (1) ZA201704591B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI739666B (zh) * 2015-01-09 2021-09-11 日商小野藥品工業股份有限公司 醫藥組成物
CR20180323A (es) 2015-11-20 2018-08-06 Idorsia Pharmaceuticals Ltd Derivados de indol n-sustituídos como moduladores de los receptores de pge2
TWI795362B (zh) 2016-07-07 2023-03-11 日商小野藥品工業股份有限公司 拮抗藥與免疫核查點阻礙藥而成之組合
MX388257B (es) 2017-05-18 2025-03-19 Idorsia Pharmaceuticals Ltd Derivados de pirimidina como moduladores del receptor de pge2.
AR111941A1 (es) 2017-05-18 2019-09-04 Idorsia Pharmaceuticals Ltd Derivados de pirimidina como moduladores del receptor de pge2
EP3625223B1 (en) 2017-05-18 2021-08-11 Idorsia Pharmaceuticals Ltd Pyrimidine derivatives
JP7093791B2 (ja) 2017-05-18 2022-06-30 イドーシア ファーマシューティカルズ リミテッド Pge2レセプター調節剤としてのベンゾフラン及びベンゾチオフェン誘導体
US20200069686A1 (en) 2017-05-18 2020-03-05 Idorsia Pharmaceuticals Ltd N-substituted indole derivatives
ES2954717T3 (es) 2017-05-22 2023-11-23 Ono Pharmaceutical Co Antagonista de EP4
US10617667B2 (en) 2017-11-01 2020-04-14 Ono Pharmaceutical Co., Ltd. Method for treating brain tumors
CN112300019A (zh) * 2019-07-31 2021-02-02 华东师范大学 一种邻乙酰氨基苯丁酸类化合物的制备方法
EP4245301A4 (en) 2020-11-13 2024-08-21 ONO Pharmaceutical Co., Ltd. TREATMENT OF CANCER BY COMBINED USE OF AN EP4 ANTAGONIST AND AN IMMUNE CHECKPOINT INHIBITOR
JP2024016314A (ja) * 2020-12-24 2024-02-07 小野薬品工業株式会社 一般式(i-a)で示される化合物、その薬学的に許容される塩、またはそれらの水和物と免疫チェックポイント阻害薬および/またはep4受容体拮抗薬との組み合わせ
CN114790186A (zh) * 2021-01-25 2022-07-26 武汉人福创新药物研发中心有限公司 作为ep4拮抗剂的稠环化合物及其制备方法和用途
CN117377656A (zh) * 2021-05-28 2024-01-09 南京明德新药研发有限公司 苯并螺杂环衍生物及其应用
JP7205657B1 (ja) 2021-08-10 2023-01-17 小野薬品工業株式会社 Ep4アンタゴニストの製造方法
TW202542134A (zh) * 2023-12-22 2025-11-01 日商Agc股份有限公司 新穎之ep4拮抗劑
WO2025212569A1 (en) 2024-04-05 2025-10-09 Park City Bio, LLC Selective serotonin receptor modultors and methods of making and using the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081679A1 (en) 1991-11-27 1993-05-28 Raj N. Misra Gem-dialkyl-7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US6242493B1 (en) * 1998-03-13 2001-06-05 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
WO1999047497A2 (en) 1998-03-13 1999-09-23 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
JP2002506851A (ja) * 1998-03-13 2002-03-05 メルク フロスト カナダ アンド カンパニー カルボン酸類およびアシルスルホンアミド類、そのような化合物を含む組成物ならびに治療方法
US6211197B1 (en) 1998-10-07 2001-04-03 Merck Frosst Canada & Co. Prostaglandin receptor ligands
WO2002016311A1 (en) * 2000-08-22 2002-02-28 Ono Pharmaceutical Co., Ltd. Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
GB0031302D0 (en) * 2000-12-21 2001-01-31 Glaxo Group Ltd Napthalene derivatives
BR0211810A (pt) * 2001-08-09 2004-08-24 Ono Pharmaceutical Co Derivados ácido carboxìlico e agente farmacêutico compreendendo os mesmos como ingrediente ativo
JP4547912B2 (ja) 2002-03-05 2010-09-22 小野薬品工業株式会社 8−アザプロスタグランジン誘導体化合物およびその化合物を有効成分として含有する薬剤
WO2004037247A1 (en) 2002-10-21 2004-05-06 Irm Llc Oxindoles with anti-hiv activity
SI2476667T1 (sl) * 2003-02-26 2014-10-30 Sugen, Inc. Aminoheteroarilne spojine kot inhibitorji protein-kinaze
CN1950334A (zh) 2004-05-04 2007-04-18 辉瑞有限公司 邻位取代的芳基或杂芳基酰胺化合物
GB0808282D0 (en) 2008-05-07 2008-06-11 Medical Res Council Compounds for use in stabilizing p53 mutants
WO2012071458A1 (en) * 2010-11-22 2012-05-31 Array Biopharma Inc. Heterocyclic inhibitors of beta - secretase for the treatment of neurodegenerative diseases
US9181279B2 (en) 2011-07-04 2015-11-10 Rottapharm Biotech S.R.L. Cyclic amine derivatives as EP4 receptor antagonists
WO2013090552A1 (en) 2011-12-13 2013-06-20 Yale University Compositions and methods for reducing ctl exhaustion
WO2015000949A1 (en) 2013-07-03 2015-01-08 F. Hoffmann-La Roche Ag Heteroaryl pyridone and aza-pyridone amide compounds
TWI739666B (zh) * 2015-01-09 2021-09-11 日商小野藥品工業股份有限公司 醫藥組成物
TWI795362B (zh) * 2016-07-07 2023-03-11 日商小野藥品工業股份有限公司 拮抗藥與免疫核查點阻礙藥而成之組合

Similar Documents

Publication Publication Date Title
JP2018080173A5 (enExample)
JP2017505762A5 (enExample)
ES2580481T3 (es) Derivados de aminoquinazolina y sus sales, y métodos de uso
RU2017124136A (ru) Трициклическое спиро-соединение
SI3022192T1 (en) Piperidinyl indole derivatives and their use as inhibitors of complementary factor B
JP2016525075A5 (enExample)
JP2019509978A5 (enExample)
JP2018515525A5 (enExample)
JP2009543867A5 (enExample)
JP2011502958A5 (enExample)
JP2010514689A5 (enExample)
JP2012532931A5 (enExample)
RU2018121499A (ru) Гипоксантины в качестве ингибиторов убиквитин-специфической протеазы 1
JP2017502940A5 (enExample)
JP2016505042A5 (enExample)
JP2011521911A5 (enExample)
JP2014524441A5 (enExample)
IL298983A (en) Macrocyclines with P2' heterocyclic groups as factor XIA inhibitors
JP2017533958A5 (enExample)
JP2017515844A5 (enExample)
JP2014513110A5 (enExample)
JP2013500997A5 (enExample)
JP2004175807A5 (enExample)
JP2012528166A5 (enExample)
JPWO2020017587A5 (enExample)